Quantifying Diagnostic Signal Decay in Dementia: A National Study of Medicare Hospitalization Data
Authors:
Federica Spoto,
Jiazi Tian,
Jonas Hügel,
Daniel T. Ortega,
Christine S. Ritchie,
Deborah Blacker,
Francesca Dominici,
Chirag J. Patel,
Daniel Mork,
Hossein Estiri
Abstract:
Background: Artificial intelligence (AI) models in healthcare depend on the fidelity of diagnostic data, yet the quality of such data is often compromised by variability in clinical documentation practices. In dementia, a condition already prone to diagnostic ambiguity, this variability may introduce systematic distortion into claims-based research and AI model development.
Methods: We analyzed…
▽ More
Background: Artificial intelligence (AI) models in healthcare depend on the fidelity of diagnostic data, yet the quality of such data is often compromised by variability in clinical documentation practices. In dementia, a condition already prone to diagnostic ambiguity, this variability may introduce systematic distortion into claims-based research and AI model development.
Methods: We analyzed Medicare Part A hospitalization data from 2016-2018 to examine patterns of dementia-related ICD-10 code utilization across more than 3,000 U.S. counties. Using a clinically informed classification of 17 ICD-10 codes grouped into five diagnostic categories, we applied the transitive Sequential Pattern Mining (tSPM+) algorithm to model temporal usage structures. We then used matrix similarity methods to compare local diagnostic patterns to national norms and fit multivariable linear regressions to identify county-level demographic and structural correlates of divergence.
Findings: We found substantial geographic and demographic variation in dementia-related diagnostic code usage. Non-specific codes were dominant nationwide, while Alzheimer's disease and vascular dementia codes showed pronounced variability. Temporal sequence analysis revealed consistent transitions from specific to non-specific codes, which suggest degradation of diagnostic specificity over time. Counties with higher proportions of rural residents, Medicaid-eligible patients, and Black or Hispanic dementia patients demonstrated significantly lower similarity to national usage patterns. Our model explained 38% of the variation in local-to-national diagnostic alignment.
△ Less
Submitted 17 June, 2025;
originally announced June 2025.
Individualized Prediction of COVID-19 Adverse outcomes with MLHO
Authors:
Hossein Estiri,
Zachary H. Strasser,
Shawn N. Murphy
Abstract:
We developed MLHO (pronounced as melo), an end-to-end Machine Learning framework that leverages iterative feature and algorithm selection to predict Health Outcomes. MLHO implements iterative sequential representation mining, and feature and model selection, for predicting the patient-level risk of hospitalization, ICU admission, need for mechanical ventilation, and death. It bases this prediction…
▽ More
We developed MLHO (pronounced as melo), an end-to-end Machine Learning framework that leverages iterative feature and algorithm selection to predict Health Outcomes. MLHO implements iterative sequential representation mining, and feature and model selection, for predicting the patient-level risk of hospitalization, ICU admission, need for mechanical ventilation, and death. It bases this prediction on data from patients' past medical records (before their COVID-19 infection). MLHO's architecture enables a parallel and outcome-oriented model calibration, in which different statistical learning algorithms and vectors of features are simultaneously tested to improve the prediction of health outcomes. Using clinical and demographic data from a large cohort of over 13,000 COVID-19-positive patients, we modeled the four adverse outcomes utilizing about 600 features representing patients' pre-COVID health records and demographics. The mean AUC ROC for mortality prediction was 0.91, while the prediction performance ranged between 0.80 and 0.81 for the ICU, hospitalization, and ventilation. We broadly describe the clusters of features that were utilized in modeling and their relative influence for predicting each outcome. Our results demonstrated that while demographic variables (namely age) are important predictors of adverse outcomes after a COVID-19 infection, the incorporation of the past clinical records are vital for a reliable prediction model. As the COVID-19 pandemic unfolds around the world, adaptable and interpretable machine learning frameworks (like MLHO) are crucial to improve our readiness for confronting the potential future waves of COVID-19, as well as other novel infectious diseases that may emerge.
△ Less
Submitted 29 December, 2020; v1 submitted 9 August, 2020;
originally announced August 2020.
